Methods: A retrospective - prospective study of all infants born ≤27 weeks associated with RDS receiving surfactant therapy who were administered paracetamol IV for PDA closure after the failure of PDA prophylaxis with paracetamol IV from April 1st. 2018 to February 28, 2021 at NICU of Childrens Hospital 1.